Middle East & Africa Opioids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Immediate Release Short Acting Opioid and Extended Release Long Acting Opioid), Application (Pain Management, Anesthesia, Diarrhea Suppression, Cough Suppression, De-Addiction, and Others), Route of Administration (Oral, Injectable, and Transdermal Patch), and Distribution Channel (Hospital Pharmacies and Retail Pharmacies)

No. of Pages: 84    |    Report Code: BMIRE00031007    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Opioids Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East & Africa Opioids Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East & Africa Opioids Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Geriatric population
5.2 Market Opportunities
  • 5.2.1 Strategic Initiatives by Market Players
5.3 Future Trends
  • 5.3.1 Increasing Government Initiatives Focusing on the Development of Medication to Prevent and Treat Opioid Use Overdose and Disorder
5.4 Impact of Drivers and Restraints

6. Middle East & Africa Opioids Market Regional Analysis

6.1 Middle East & Africa Opioids Market Overview
6.2 Middle East & Africa Opioids Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Opioids Market Forecast Analysis

7. Middle East & Africa Opioids Market Analysis – by Product

7.1 Immediate Release Short Acting Opioid
  • 7.1.1 Overview
  • 7.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Extended Release Long Acting Opioid
  • 7.2.1 Overview
  • 7.2.2 Extended Release Long Acting Opioid: Middle East & Africa Opioids Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Opioids Market Analysis – by Application

8.1 Pain Management
  • 8.1.1 Overview
  • 8.1.2 Pain Management: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
  • 8.2.1 Overview
  • 8.2.2 Anesthesia: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhea Suppression
  • 8.3.1 Overview
  • 8.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
  • 8.4.1 Overview
  • 8.4.2 Cough Suppression: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
  • 8.5.1 Overview
  • 8.5.2 De-Addiction: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Opioids Market Analysis – by Route of Administration

9.1 Oral
  • 9.1.1 Overview
  • 9.1.2 De-Addiction: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
  • 9.2.1 Overview
  • 9.2.2 De-Addiction: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
  • 9.3.1 Overview
  • 9.3.2 De-Addiction: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Opioids Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East & Africa Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 Middle East & Africa Opioids Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product
    • 10.1.1.1.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Application
    • 10.1.1.1.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Route of Administration
  • 10.1.1.2 Saudi Arabia: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product
    • 10.1.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application
    • 10.1.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route of Administration
  • 10.1.1.3 UAE: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East & Africa Opioids Market Breakdown, by Product
    • 10.1.1.3.2 UAE: Middle East & Africa Opioids Market Breakdown, by Application
    • 10.1.1.3.3 UAE: Middle East & Africa Opioids Market Breakdown, by Route of Administration
  • 10.1.1.4 Rest of Middle East and Africa: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Product
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Application
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East & Africa Opioids Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Neuraxpharm Pharmaceuticals SL
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Endo International plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Hikma Pharmaceuticals Plc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Mallinckrodt Plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Rusan Pharma Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Teva Pharmaceutical Industries Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

  1. Neuraxpharm Pharmaceuticals SL
  2. Endo International plc
  3. Hikma Pharmaceuticals Plc
  4. Mallinckrodt Plc
  5. Rusan Pharma Ltd
  6. Teva Pharmaceutical Industries Ltd
middle-east-and-africa-opioids-market